Advances in Carcinogenesis Research -

Advances in Carcinogenesis Research

Masayoshi Yamaguchi (Herausgeber)

Buch | Softcover
111 Seiten
2017
Nova Science Publishers Inc (Verlag)
978-1-63485-849-6 (ISBN)
123,20 inkl. MwSt
This book introduces recent topics regarding carcinogenesis, including manifold findings of cell proliferation biology, abnormal cell division, pathophysiology, diagnosis, prevention and treatment implicated in the fields of cancer. Carcinogenesis is a multistep process initiated by external stimuli that lead to genetic changes in normal cells or stem cells, resulting in proliferation, apoptosis, dysplasia and neoplasia. The expression, post-translational processing, and targeting of the gene products are frequently altered in transformed and malignant cells. Currently, prognosis of advanced cancer remains poor in spite of the development of novel therapeutic strategies. Improved knowledge of the oncogenic processes and signaling pathways that regulate tumor cell proliferation, differentiation, angiogenesis, invasion and metastatis has led to the identification of several potential therapeutic targets, which have driven the development of molecularly targeted therapies. The target is drugable, as an enzyme (kinase) or cell surface molecule (membrane-bound receptors) that can be easily screened for small-molecule inhibitors or targeted by a specific antibody. New perspectives in cancer treatment have appeared with the advent of microRNAs, a novel class of noncoding small RNAs. Moreover, identification of the genes that are differentially expressed between sensitive and resistant cancer cells for chemotherapy and radiation is important in the ability to predict the clinical effectiveness of therapy and develop new therapeutic tools. This book provides recently discovered information concerning cancer biology as well as translational treatment for cancer patients.

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013 - ). Dr. Yamaguchi is engaged in the fields of endocrinology and cell signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetes and diabetic osteoporosis, cancer biology, and cancer cell bone metastasis. Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001). Dr Yamaguchi generated regucalcin transgenic rats, which were registered as international patents including USA, EU and Japan, and this animal was found to induce osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential role of regucalcin as a key suppressor protein in carcinogenesis. Thus far, Dr Yamaguchi published over 550 English articles to professional journals with peer-review, and registered over 20 national and international patents.

For Complete Table of Contents, please visit our website at: https://www.novapublishers.com/catalog/product_info.php?products_id=60194

Erscheinungsdatum
Verlagsort New York
Sprache englisch
Maße 155 x 230 mm
Gewicht 222 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
ISBN-10 1-63485-849-2 / 1634858492
ISBN-13 978-1-63485-849-6 / 9781634858496
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99